Targeting tumour necrosis factor-α in hypoxia and synaptic signalling

Irish Journal of Medical Science

Volumn 182, Issue 2, 2013, Pages 157-162

  O'Connor, J J ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Hippocampus; Hypoxia; Inflammation; Prolyl hydroxylase; Synaptic plasticity; Synaptic transmission; TNF

Indexed keywords

CASPASE 8; CHLORPHENIRAMINE MALEATE PLUS PHENYLEPHRINE; EXCITATORY AMINO ACID TRANSPORTER; HYPOXIA INDUCIBLE FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METABOTROPIC RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; CYTOKINE; NEUROPROTECTIVE AGENT;

APOPTOSIS; ARTICLE; ASTROCYTE; BRAIN TISSUE; CALCIUM CELL LEVEL; CALCIUM CURRENT; CELL MEMBRANE; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM; ENDOTHELIUM CELL; EXTRACELLULAR SPACE; GLIA CELL; HIPPOCAMPUS; HOMEOSTASIS; HYPOXIA; LONG TERM DEPRESSION; LONG TERM POTENTIATION; MEMORY CONSOLIDATION; NERVE CELL PLASTICITY; NEUROMODULATION; NONHUMAN; OXIDATIVE STRESS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION; UPREGULATION; VASCULARIZATION; BRAIN; DRUG EFFECT; HUMAN; METABOLISM; NERVE CELL; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

APOPTOSIS; BRAIN; CYTOKINES; HUMANS; NEURONS; NEUROPROTECTIVE AGENTS; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION; TUMOR NECROSIS FACTOR-ALPHA;

MLCS; MLOWN;

EID: 84878353280     PISSN: 00211265     EISSN: 18634362     Source Type: Journal    
DOI: 10.1007/s11845-013-0911-4     Document Type: Article

References (66)

1. Carswell EA, Old LJ, Kassel RL (1975) An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 72:3666-3670
2. Lieberman AP, Pitha PM, Shin HS et al (1989) Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. Proc Natl Acad Sci USA 86:6348-6352
3. Cacci E, Claasen JH, Kokaia Z (2005) Microglia-derived tumor necrosis factor-alpha exaggerates death of newborn hippocampal progenitor cells in vitro. J Neurosci Res 80:789-797
4. Kogo J, Takeba Y, Kumai T et al (2006) Involvement of TNF-α in glutamate-induced apoptosis in a differentiated neuronal cell line. Brain Res 1122:201-208
5. Tchelingerian JL, Le Saux F, Jacque C (1996) Identification and topography of neuronal cell populations expressing TNF alpha and IL-1 alpha in response to hippocampal lesion. J Neurosci Res 43:99-106
6. Black RA, Rauch CT, Kozlosky CJ et al (1997) A metalloproteinase disintegrin that releases tumour-necrosis factor-[alpha] from cells. Nature 385:729-733
7. Jelinek DF, Lipsky PE (1987) Enhancement of human B cell proliferation and differentiation by tumor necrosis factor-alpha and interleukin 1. J Immunol 139:2970-2976
8. Murphy M, Perussia B, Trinchieri G (1988) Effects of recombinant tumor necrosis factor, lymphotoxin, and immune interferon on proliferation and differentiation of enriched hematopoietic precursor cells. Exp Hematol 16:131-138
9. Collins T, Lapierre LA, Fiers W (1986) Recombinant human tumor necrosis factor increases mRNA levels and surface expression of HLA-A, B antigens in vascular endothelial cells and dermal fibroblasts in vitro. Proc Natl Acad Sci USA 83:446-450
10. Grilli M, Chen-Tran A, Lenardo MJ (1993) Tumor necrosis factor alpha mediates a T cell receptor-independent induction of the gene regulatory factor NF-kappa B in T lymphocytes. Mol Immunol 30:1287-1294
11. Wilde GJ, Pringle AK, Sundstrom LE et al (2000) Attenuation and augmentation of ischaemia-related neuronal death by tumour necrosis factor-alpha in vitro. Eur J Neurosci 12:3863-3870
12. Ginis I, Jaiswal R, Klimanis D et al (2002) TNF-α-induced tolerance to ischemic injury involves differential control of NF-kappaB transactivation: the role of NF-kappaB association with p300 adaptor. J Cereb Blood Flow Metab 22:142-152
13. Bessler H, Djaldetti R, Salman H et al (1999) IL-1 beta, IL-2, IL-6 and TNF-α production by peripheral blood mononuclear cells from patients with Parkinson's disease. Biomed Pharmacother 53:141-145
14. Goodman JC, Robertson CS, Grossman RG et al (1990) Elevation of tumor necrosis factor in head injury. J Neuroimmunol 30:213-217
15. Hofman FM, Hinton DR, Johnson K et al (1989) Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med 170:607-612
16. Liu T, Clark RK, Mcdonnell PC et al (1994) Tumor necrosis factor-alpha expression in ischemic neurons. Stroke 25:1481-1488
17. Musumeci G, Grasselli G, Rossi S et al (2011) Transient receptor potential vanilloid 1 channels modulate the synaptic effects of TNF-α and of IL-1β in experimental autoimmune encephalomyelitis. Neurobiol Dis 43:669-677
18. Pickering M, Cumiskey D, O'Connor JJ (2005) Actions of TNF-α on glutamatergic synaptic transmission in the central nervous system. Exp Physiol 90:663-670
19. Pickering M, O'Connor JJ (2007) Pro-inflammatory cytokines and their effects in the dentate gyrus. Prog Brain Res 163:339-354
20. Dziewulska D, Mossakowski MJ (2003) Cellular expression of tumor necrosis factor a and its receptors in human ischemic stroke. Clin Neuropathol 22:35-40
21. Figiel I, Dzwonek K (2007) TNF[alpha] and TNF receptor 1 expression in the mixed neuronal-glial cultures of hippocampal dentate gyrus exposed to glutamate or trimethyltin. Brain Res 1131:17-28
22. Dopp JM, Mackenzie-Graham A, Otero GC et al (1997) Differential expression, cytokine modulation, and specific functions of type-1 and type-2 tumor necrosis factor receptors in rat glia. J Neuroimmunol 75:104-112
23. Bebo B, Linthicum DS (1995) Expression of mRNA for 55-kDa and 75-kDa tumor necrosis factor (TNF) receptors in mouse cerebrovascular endothelium: effects of interleukin-1 beta, interferon-gamma and TNF-α on cultured cells. J Neuroimmunol 62:161-167
24. Tartaglia LA, Weber RF, Figari IS et al (1991) The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc Natl Acad Sci USA 88:9292-9296
25. Chen G, Goeddel DV (2002) TNF-R1 signaling: a beautiful pathway. Science 296:1634-1635
26. Schneider-Brachert W, Tchikov V, Neumeyer J et al (2004) Compartmentalization of TNF receptor 1 signaling: internalized TNF receptosomes as death signaling vesicles. Immunity 21:415-428
27. Marchetti L, Klein M, Schlett K et al (2004) Tumor necrosis factor (TNF)-mediated neuroprotection against glutamate-induced excitotoxicity is enhanced by N-methyl-d-aspartate receptor activation. Essential role of a TNF receptor 2-mediated phosphatidylinositol 3-kinase-dependent NF-kappa B pathway. J Biol Chem 279:32869-32881
28. MacEwan DJ (2002) TNF receptor subtype signalling: differences and cellular consequences. Cell Signal 14:477-492
29. Beattie EC, Stellwagen D, Morishita W et al (2002) Control of synaptic strength by glial TNF-α. Science 295:2282-2285
30. Furukawa K, Mattson MP (1998) The transcription factor NF-kappaB mediates increases in calcium currents and decreases in NMDA- and AMPA/kainate-induced currents induced by tumor necrosis factor-alpha in hippocampal neurons. J Neurochem 70:1876-1886
31. Stellwagen D, Malenka RC (2006) Synaptic scaling mediated by glial TNF-α. Nature 440:1054-1059
32. Stellwagen D, Beattie EC, Seo JY et al (2005) Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha. J Neurosci 25:3219-3228
33. Stellwagen D (2011) The contribution of TNFα to synaptic plasticity and nervous system function. Adv Exp Med Biol 691:541-557
34. He P, Liu Q, Wu J et al (2012) Genetic deletion of TNF receptor suppresses excitatory synaptic transmission via reducing AMPA receptor synaptic localization in cortical neurons. FASEB J 26:334-345
35. Watters O, Pickering M, O'Connor JJ (2011) Preconditioning effects of tumor necrosis factor-α and glutamate on calcium dynamics in rat organotypic hippocampal cultures. J Neuroimmunol 234:27-39
36. Santello M, Bezzi P, Volterra A (2011) TNFα controls glutamatergic gliotransmission in the hippocampal dentate gyrus. Neuron 69:988-1001
37. Tancredi V, D'Arcangelo G, Grassi F et al (1992) Tumor necrosis factor alters synaptic transmission in rat hippocampal slices. Neurosci Lett 146:176-178
38. Cunningham AJ, Murray CA, O'Neill LAJ et al (1996) IL-1b and tumour necrosis factor-a inhibit LTP in the rat dentate gyrus in vitro. Neurosci Lett 203:17-20
39. Butler M, O'Connor JJ, Moynagh P (2004) Dissection of TNF-α inhibition of LTP reveals a p38 MAPK-dependent mechanism which maps to early but not late-phase LTP. Neuroscience 124:319-326
40. Curran BP, Murray H, O'Connor JJ (2003) A role for c-jun n-terminal kinase in the inhibition of long-term potentiation by IL-1b and long-term depression in the rat dentate gyrus in vitro. Neuroscience 118:347-357
41. Coogan A, O'Neill LAJ, O'Connor JJ (1999) The p38 MAP kinase inhibitor SB203580 antagonises the inhibitory effect of interleukin-1b on long-term potentiation in the rat dentate gyrus in vitro. Neuroscience 93:57-69
42. Curran B, O'Connor JJ (2001) The pro-inflammatory cytokine interleukin-18 impairs long-term potentiation and NMDA receptor-mediated transmission in the rat hippocampus in vitro. Neuroscience 108:83-90
43. Curran B, O'Connor JJ (2003) The inhibition of long-term potentiation by pro-inflammatory cytokines is attenuated in the presence of nicotine. Neurosci Lett 344:103-106
44. Cumiskey D, Butler MP, Moynagh PN et al (2006) Evidence for a role for the group 1 metabotropic glutamate receptor in the inhibitory effect of tumour necrosis factor-α on long-term potentiation. Brain Res 1136:13-19
45. Albensi BC, Mattson MP (2000) Evidence for the involvement of TNF and NF-kappaB in hippocampal synaptic plasticity. Synapse 35:151-159
46. Perea G, Araque A (2005) Synaptic regulation of the astrocyte calcium signal. J Neural Transm 112:127-135
47. Ikeda E (2005) Cellular response to tissue hypoxia and its involvement in disease progression. Pathol Int 55:603-610
48. Ratan RR, Siddiq A, Smirnova N et al (2007) Harnessing hypoxic adaptation to prevent, treat, and repair stroke. J Mol Med 85:1331-1338
49. Trincavelli ML, Marroni M, Tuscano D et al (2004) Regulation of A2B adenosine receptor functioning by tumour necrosis factor a in human astroglial cells. J Neurochem 91:1180-1190
50. Trincavelli ML, Tonazzini I, Montali M et al (2008) Short-term TNF-alpha treatment induced A2B adenosine receptor desensitization in human astroglial cells. J Cell Biochem 104:150-161
51. Row BW, Liu R, Xu W et al (2003) Intermittent hypoxia is associated with oxidative stress and spatial learning deficits in the rat. Am J Respir Crit Care Med 167:1548-1553
52. Zhan G, Serrano F, Fenik P et al (2005) NADPH oxidase mediates hypersomnolence and brain oxidative injury in a murine model of sleep apnoea. Am J Respir Crit Care Med 172:921-929
53. Tam CS, Wong M, Tam K et al (2007) The effect of acute intermittent hypercapnic hypoxia treatment on IL-6, TNF-α, and CRP levels in piglets. Sleep 30:723-727
54. Ryan S, Taylor CT, McNicholas WT (2006) Predictors of elevated nuclear factor-kappaB-dependent genes in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 174:824-830
55. Savransky V, Bevans S, Nanayakkara A et al (2007) Chronic intermittent hypoxia causes hepatitis in a mouse model of diet-induced fatty liver. Am J Physiol Gastrointest Liver Physiol 293:G871-G877
56. Bullock R, Zauner A, Woodward J et al (1995) Massive persistent release of excitatory amino acids following human occlusive stroke. Stroke 26:2187-2189
57. Bruce AJ, Boling W, Kindy MS et al (1996) Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat Med 2:788-794
58. Burkovetskaya ME, Levin SG, Godukhin OV (2007) Neuroprotective effects of interleukin-10 and tumor necrosis factor-alpha against hypoxia-induced hyperexcitability in hippocampal slice neurons. Neurosci Lett 416:236-240
59. Zhou J, Fandrey J, Schümann J et al (2003) NO and TNF-α released from activated macrophages stabilize HIF-1alpha in resting tubular LLC-PK1 cells. Am J Physiol Cell Physiol 284:C439-C446
60. Jung Y, Isaacs JS, Lee S et al (2003) Hypoxia-inducible factor induction by tumour necrosis factor in normoxic cells requires receptor-interacting protein-dependent nuclear factor kappa B activation. Biochem J 370:1011-1017
61. Goel G, Guo M, Ding J et al (2010) Combined effect of tumor necrosis factor (TNF)-alpha and heat shock protein (HSP)-70 in reducing apoptotic injury in hypoxia: a cell culture study. Neurosci Lett 483:162-166
62. Badiola N, Malagelada C, Llecha N et al (2009) Activation of caspase-8 by tumour necrosis factor receptor 1 is necessary for caspase-3 activation and apoptosis in oxygen-glucose deprived cultured cortical cells. Neurobiol Dis 35:438-447
63. Echeverry R, Wu F (2012) Haile WB (2012) The cytokine tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 have a neuroprotective effect in the central nervous system. J Neuroinflammation 9:45
64. Batti L, O'Connor JJ (2010) Tumor necrosis factor-α impairs the recovery of synaptic transmission from hypoxia in rat hippocampal slices. J Neuroimmunol 218:21-27
65. Corcoran A, O'Connor JJ (2010) The effects of hypoxia, prolyl hydroxylase inhibition and TNF-α on synaptic transmission in the rat hippocampus. Proc Br Pharm Soc Winter Meet 8(1):157
66. Wall AM, O'Connor JJ (2011) Acute hypoxia impairs the recovery of synaptic transmission in the rat dentate gyrus and potentiates long-term potentiation in the presence of tumour necrosis factor-α and picrotoxin. Ir J Med Sci 180(Suppl 2):56